AI summary by TwinMind
56. Snake Venom | The Economics of Everyday Things
Freakonomics Radio Network
22m 20s
Personal Story - Sean Bush's Son Snake Bite (2006)
- Sean Bush: Emergency physician specializing in venomous snake bites
- Son Jude (2 years old) bitten by juvenile rattlesnake between thumb and index finger
- Lived in "sneakiest plateau in Southern California"
- Bush had antivenom ready, met helicopter on helipad
- Son recovered successfully due to immediate expert treatment
Snake Bite Context and Statistics
- Venomous snakes bite millions globally, causing tens of thousands of deaths
- US: Snake bite treatment costs $100,000-$200,000 easily
- Worldwide: 3,000+ snake species, 600 venomous, 200 deadly to humans
- US: ~20 venomous species, mostly coral snakes and pit vipers (rattlesnakes, copperheads, cottonmouths)
- Annual US statistics: <10,000 venomous bites, average 5 deaths
Venom Week Conference
- 9th Annual Venom Week, Durham Convention Center, North Carolina
- Topics: rattlesnake relocation, snake bite economics in Nepal, thrombotic microangiopathy
- Attendees: doctors, scientists, herpetologists, enthusiasts
- Sean Bush: President of North American Society of Toxinology
Snake Behavior and Venom Types
- Snakes reluctant to bite humans - biologically expensive venom production
- Venom used primarily for food digestion
- Different venom types:
- Neurotoxins: paralyze, prevent breathing
- Blood-affecting: cause clots or hemorrhaging
- Pit viper venom: necrotic, breaks down flesh, proteolytic enzymes
- Untreated bites: amputation, kidney failure, death within hours/days
Ineffective Treatment Methods
- Tourniquets, plunger devices, whiskey/cutting/sucking method all harmful
- Only effective treatment: hospital antivenom
- Antivenom: drug from antibodies that bind to venom, prevent further harm
Venom Production - Jack Facente/Aggri Toxins
- One of few US businesses extracting snake venom
- Specializes in coral snake venom for Pfizer
- St Cloud, Florida facility: ~60 coral snakes
- Coral snakes: subterranean, hard to catch
- 2-year collection effort: St Cloud to Ocala North to Lake City, Tampa to Jacksonville
- Milking process: every 2-3 weeks, fangs against fabric over test tube
- Yield amounts:
- Small snakes: 3-4 milligrams
- Larger snakes: 18-20 milligrams
- 6' Eastern Diamond Back: equivalent to 150 coral snakes
- Big Eastern Diamond Backs: 700-800 milligrams per bite
- Single gram powder requires milking 125 snakes
- Pricing: $300-$6,000 per gram depending on species
- Coral snake: $6,000 per gram
- Larger rattlesnakes/vipers: hundreds of dollars
- Small US market: manufacturers buy few hundred milligrams at a time
Antivenom Manufacturing
Pfizer (Coral Snake Antivenom)
- Sole US producer of North American coral snake antivenom
Serb Pharmaceuticals (CroFab)
- Owns BTG International
- 1,000+ snakes in Salt Lake City facility
- Four US species: Western Diamond Back, Eastern Diamond Back, cottonmouth, Mojave rattlesnake
- Complex international process:
- Venom extraction (Florida/Salt Lake City)
- Purification (Wales lab)
- Sheep injection (Australia)
- 18-month antibody development
- Blood harvesting, antibody extraction
- Final purification (Wales)
- US distribution through wholesalers like McKesson
- Wholesale price: ~$3,800 per vial
- Costs include production, R&D ($5-10 million per trial)
Hospital Economics and Access
- Loma Linda University Medical Center: stocked 200 vials despite high costs
- Smaller hospitals: barely afford single-patient treatment
- Urgent care centers: cannot afford to stock antivenom
- Hospital charges: $15,000+ per vial (many times wholesale price)
Patient Cost Examples
- 2018 Illinois family: $68,000 for 4 vials (9-year-old daughter)
- Additional $58,000 helicopter ride
- South Carolina teenager: $200,000 for 12 vials
- Family paid $175 out-of-pocket after insurance
- Uninsured patients face financial bankruptcy
- Migrant farm workers in Central Valley California particularly vulnerable
Global Snake Bite Crisis
- Annual global impact: 2.7 million people affected
- Deaths: 80,000-140,000 annually (WHO estimates)
- Permanent disabilities: ~3x death rate (amputations)
- Highest impact: Southeast Asia, Central Africa
- 2020 production: ~1 million doses (well below need)
- Manufacturers pulled out of Africa markets (unprofitable)
Global Solutions
Premium Serums and Vaccines (India)
- Niten Despande: business consultant
- Products for Asia (India, Pakistan, Bangladesh, Sri Lanka, Nepal)
- Subsaharan Africa coverage
- Egypt, Libya, Morocco, Tunisia, Algeria specific product
- Production: ~1.5 million vials annually
- Polyvalent antivenoms: neutralize multiple species (24 species for subsaharan Africa)
- Indian e-commerce pricing: 700 rupees (~$8 per vial)
- More side effects but affordable, life-saving
Asclepius Snake Bite Foundation
- Nick Brandyhoff: executive director
- Mexican manufacturer sourcing keeps costs low
- Treatment costs: $100 total per patient, $200 for severe cases
- Covers payment gaps for patients
- Clinics in Guinea, Sierra Leone, Congo Brazzaville
- Guinea results (2019 clinic): mortality dropped from 30% to <2%
Future Developments
- Oral antivenom pill research (more affordable than IV)
- Synthetic antibodies in lab (no sheep/horse needed)
- Sean Bush: "revolutionize snake bite treatment"
- Genetic cataloging and protein identification
- Jack Facente predicts venom collection obsolete in 10-20 years
Personal Impact
- Jack Facente's recent coral snake bite: 4 vials Costa Rican antivenom, 5-day hospitalization
- Lessons: "hurts, expensive, need antivenom"
